Nancy S. Reau, MD

Opinion

The Breakthrough Drug Whose Full Promise Remains Unrealized

Author:: Nancy S. Reau, MD

Publish date: January 26, 2024

With its approval in 2013, sofosbuvir revolutionized the treatment of hepatitis C, but the goal of eliminating this disease is still decades away.<...

Opinion

MASLD: Promising treatments for a newly renamed disease

Author:: Nancy S. Reau, MD

Publish date: September 15, 2023

The name change refocuses the attention of providers on the fundamental basis of MASLD as a critical member of the metabolic syndrome spectrum of d...

Opinion

HCV screening in pregnancy: Reducing the risk for casualties in the quest for elimination

Author:: Nancy S. Reau, MD

Publish date: November 23, 2021

HCV screening during pregnancy, as currently recommended, provides no immediate benefit for the pregnant woman or the fetus/neonate, given that ant...

Opinion

Vanquishing hepatitis C: A remarkable success story

Author:: Nancy S. Reau, MD

Publish date: November 20, 2020

It only took 25 years between the discovery of the HCV in 1989 to its eventual cure in 2014.